STRUCTURAL STUDIES OF HIV-1 REVERSE TRANSCRIPTASE (RT)

HIV-1 逆转录酶 (RT) 的结构研究

• 批准号: 8170670
• 负责人: EDWARD ARNOLD
• 金额: $ 0.32万
• 依托单位: BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8170670
• 关键词: Anti-HIV Agents; Computer Retrieval of Information on Scientific Projects Database; Crystallography; Funding; Grant; HIV-1; HIV-1 Reverse Transcriptase; Institution; Life Cycle Stages; Macromolecular Complexes; Methods; Nucleic Acids; Nucleosides; RNA-Directed DNA Polymerase; Research; Research Personnel; Resistance; Resources; Source; United States National Institutes of Health; Virus; effective therapy; inhibitor/antagonist; three dimensional structure

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We will prepare macromolecular complexes of HIV-1 reversetranscriptase (RT), an essential component in the life cycle of theHIV-1 virus, with nucleic acid and nucleoside and nonnucleoside reversetranscriptase inhibitors. The three dimensional structures of thesecomplexes will be determined by x-ray crystallographic methods. Throughthese studies we hope to gain a detailed understanding of thefundamental principles underlying inhibition of RT's function and theemergence of resistance to these inhibitors. Ultimately we hope toapply information garnered from our stuctural studies towards theadvancement of new and effective treatment stategies in the form ofbetter anti-HIV drugs.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 我们将制备HIV-1逆转录酶(RT)与核酸、核苷和非核苷逆转录酶抑制剂的大分子复合体。RT是HIV-1病毒生命周期中的重要组成部分。这些络合物的三维结构将由X射线结晶学方法确定。通过这些研究，我们希望详细了解抑制RT功能的基本原理以及对这些抑制剂的耐药性的出现。最终，我们希望将从我们的结构研究中获得的信息应用于以更好的抗HIV药物的形式推进新的有效治疗策略。